David Damari, OD, FCOD, FAAO

Study: Neurolenses significantly impact reading speed

FDA approves biosimilar product ranibizumab-eqrn for retinal diseases

Aerie doses first patient in COMET-3 study for DED treatment

EyeCare4Kids names new executive director